Lessons from viral manipulation of protein disposal pathways.
Furman
Margo H
MH
Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Ploegh
Hidde L
HL
D000818:Animals; D015395:Histocompatibility Antigens Class I / Q000276:immunology / Q000502:physiology; D006801:Humans; D017874:Immediate-Early Proteins / Q000502:physiology; D011506:Proteins / Q000378:metabolism*; D016601:RNA-Binding Proteins / Q000502:physiology; D025801:Ubiquitin / Q000378:metabolism; D014759:Viral Envelope Proteins / Q000502:physiology; D014764:Viral Proteins / Q000502:physiology; D014777:Virus Diseases / Q000276:immunology*
D015395:Histocompatibility Antigens Class I; D017874:Immediate-Early Proteins; C456022:K3 protein, Kaposi's sarcoma-associated herpesvirus; C405867:K5 protein, Human herpesvirus 8; D011506:Proteins; D016601:RNA-Binding Proteins; C074546:US11 protein, herpesvirus; C118670:US2 protein, Varicellovirus; D025801:Ubiquitin; D014759:Viral Envelope Proteins; D014764:Viral Proteins